The W64R variant of the β3-adrenergic receptor is not associated with Type II diabetes or obesity in a large Finnish sample
dc.contributor.author | Nylund, S. J. | en_US |
dc.contributor.author | Bergman, Richard N. | en_US |
dc.contributor.author | Magnuson, V. L. | en_US |
dc.contributor.author | Boehnke, Michael | en_US |
dc.contributor.author | Collins, Francis S. | en_US |
dc.contributor.author | Valle, Timo T. | en_US |
dc.contributor.author | Watanabe, Richard M. | en_US |
dc.contributor.author | Hauser, Elizabeth R. | en_US |
dc.contributor.author | Eriksson, J. | en_US |
dc.contributor.author | Ghosh, S. | en_US |
dc.contributor.author | Langefeld, Carl D. | en_US |
dc.contributor.author | Ally, D. | en_US |
dc.contributor.author | Tuomilehto, Jaakko | en_US |
dc.date.accessioned | 2006-09-08T19:44:40Z | |
dc.date.available | 2006-09-08T19:44:40Z | |
dc.date.issued | 1999-01 | en_US |
dc.identifier.citation | Ghosh, S.; Langefeld, C. D.; Ally, D.; Watanabe, R. M.; Hauser, E. R.; Magnuson, V. L.; Nylund, S. J.; Valle, T.; Eriksson, J.; Bergman, R. N.; Tuomilehto, J.; Collins, F. S.; Boehnke, M.; (1999). "The W64R variant of the β3-adrenergic receptor is not associated with Type II diabetes or obesity in a large Finnish sample." Diabetologia 42(2): 238-244. <http://hdl.handle.net/2027.42/41887> | en_US |
dc.identifier.issn | 0012-186X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/41887 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=10064105&dopt=citation | en_US |
dc.description.abstract | Recent studies have suggested an association between Type II (non-insulin-dependent) diabetes mellitus-related phenotypes and a cytosine-to-thymidine substitution that results in the replacement of tryptophan by arginine at codon 64 (Trp64Arg or W64R) of the β 3 -adrenergic receptor gene. Here, we present the results of possibly the largest association study to date on the variant in a sample of 526 families with a total of 1725 subjects, 1053 of whom had Type II diabetes. Preliminary calculations suggested that we had excellent power to detect the moderate associations which were reported in previous studies. No associations were found between the W64R variant and the following phenotypes in our sample: Type II diabetes, age at diagnosis for Type II diabetes, measures of obesity, fasting glucose, fasting insulin, minimal model variables, and systolic and diastolic blood pressures. In the analysis of plasma lipids, we detected an association between the variant and HDL ratios (HDL cholesterol/total cholesterol) ( p = 0.013), which remained significant even after adjusting for sex, affection status and age. Since W64R homozygotes ( n = 11) had the highest HDL ratios, however, heterozygotes had the lowest and the wild-type subjects had intermediate values, we conclude that the W64R variant is unlikely to reduce HDL ratios in a dose-dependent, pathogenic manner. [Diabetologia (1999) 42: 238–244] | en_US |
dc.format.extent | 116068 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag; Springer-Verlag Berlin Heidelberg | en_US |
dc.subject.other | Keywordsβ3-Adrenergic Receptor | en_US |
dc.subject.other | Obesity | en_US |
dc.subject.other | Type II Diabetes | en_US |
dc.subject.other | Association. | en_US |
dc.subject.other | Legacy | en_US |
dc.title | The W64R variant of the β3-adrenergic receptor is not associated with Type II diabetes or obesity in a large Finnish sample | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationum | Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, USA, US, | en_US |
dc.contributor.affiliationother | National Public Health Institute, Department of Health Promotion, Helsinki, Finland, FI, | en_US |
dc.contributor.affiliationother | Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA, US, | en_US |
dc.contributor.affiliationother | Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles, California, USA, US, | en_US |
dc.contributor.affiliationother | Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA, US, | en_US |
dc.contributor.affiliationother | National Public Health Institute, Department of Health Promotion, Helsinki, Finland, FI, | en_US |
dc.contributor.affiliationother | National Public Health Institute, Department of Health Promotion, Helsinki, Finland, FI, | en_US |
dc.contributor.affiliationother | National Public Health Institute, Department of Health Promotion, Helsinki, Finland, FI, | en_US |
dc.contributor.affiliationother | Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA, US, | en_US |
dc.contributor.affiliationother | Genetics and Molecular Biology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA, US, | en_US |
dc.contributor.affiliationother | Section of Medical Genetics, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA, US, | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 10064105 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/41887/1/125-42-2-238_90420238.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s001250051144 | en_US |
dc.identifier.source | Diabetologia | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.